Strategies for cancer prevention involving reduction or elimination of human exposure to environmental carcinogens may not always be possible. Inhibition of the development of cancer by the administration of anticarcinogenic agents may offer a practical alternative for reducing human cancer burden. However, the successful utilization of chemoprotective interventions will require solid mechanistic understanding of the action(s) of these agents. The proposed study will continue to investigate the modes of protection afforded by oltipraz and other 1,2-dithiole-3-thiones on aflatoxin B1 hepatocarcinogenesis in the rat. Oltipraz is an effective and potent inhibitor of experimental carcinogenesis in may tissues and holds strong promise for use in human interventions. Specifically, we will investigate the chemistry of dithiolethiones with respect to (a) new methods for synthesis of these related molecules; (b) synthesis of compounds designed to test emerging structure-activity relationships, leading to more active compounds; (c) synthesis of oltipraz metabolites for evaluation in bioassays; (d) synthesis of radiolabeled dithiolethiones for mechanistic studies; and (e) synthesis of dithiolethiones suitable for production of antibodies. We will also investigate the structure-activity relationships of the synthesized compounds on (a) phase I & II enzyme activities; (b) mechanisms of induction of phase II enzymes: (c) altered carcinogen-DNA adduct formation; and (d) inhibition of AFB1-induced tumorigenesis in rats. Finally, we will utilize a molecular genetic approach to identify and characterize the spectrum of genes induced by dithiolethiones in rat liver. A cDNA library prepared from the livers of rats treated with 1,2- dithiole-3-thione will be screened by differential/subtractive hybridization techniques. Isolated clones will then be identified and characterized by hybridization and DNA sequence analyses. Collectively, these multifaceted, integrated studies will more fully define the chemical, molecular, biochemical and biological mechanisms of action of this of this versatile class of chemoprotective agents. The long term goal of this work is to facilitate the most efficient and effective use dithiolethiones as protective agents in human populations exposed to environmental toxicants.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA039416-13
Application #
2654000
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1985-09-01
Project End
1999-01-31
Budget Start
1998-02-01
Budget End
1999-01-31
Support Year
13
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Wible, Ryan S; Tran, Quynh T; Fathima, Samreen et al. (2018) Pharmacogenomics of Chemically Distinct Classes of Keap1-Nrf2 Activators Identify Common and Unique Gene, Protein, and Pathway Responses In Vivo. Mol Pharmacol 93:297-308
Johnson, Natalie M; Egner, Patricia A; Baxter, Victoria K et al. (2014) Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold. Cancer Prev Res (Phila) 7:658-65
Fasullo, Michael; Smith, Autumn; Egner, Patricia et al. (2014) Activation of aflatoxin B1 by expression of human CYP1A2 polymorphisms in Saccharomyces cerevisiae. Mutat Res Genet Toxicol Environ Mutagen 761:18-26
Kensler, Kevin H; Slocum, Stephen L; Chartoumpekis, Dionysios V et al. (2014) Genetic or pharmacologic activation of Nrf2 signaling fails to protect against aflatoxin genotoxicity in hypersensitive GSTA3 knockout mice. Toxicol Sci 139:293-300
Kensler, Thomas W; Egner, Patricia A; Agyeman, Abena S et al. (2013) Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. Top Curr Chem 329:163-77
Takaya, Kai; Suzuki, Takafumi; Motohashi, Hozumi et al. (2012) Validation of the multiple sensor mechanism of the Keap1-Nrf2 system. Free Radic Biol Med 53:817-27
Wogan, Gerald N; Kensler, Thomas W; Groopman, John D (2012) Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 29:249-57
Koissi, Niangoran; Shah, Niti H; Ginevan, Brandon et al. (2012) Lactone metabolite common to the carcinogens dioxane, diethylene glycol, and N-nitrosomorpholine: aqueous chemistry and failure to mediate liver carcinogenesis in the F344 rat. Chem Res Toxicol 25:1022-8
Fahey, Jed W; Talalay, Paul; Kensler, Thomas W (2012) Notes from the field: ""green"" chemoprevention as frugal medicine. Cancer Prev Res (Phila) 5:179-88
Kensler, Thomas W; Roebuck, Bill D; Wogan, Gerald N et al. (2011) Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicol Sci 120 Suppl 1:S28-48

Showing the most recent 10 out of 116 publications